Stribild
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
61958-1201 -
Package NDC
61958-1201-1 -
Application number
NDA203100 -
SPL ID
65c2d2eb-d180-41c3-b346-9cdc6e52d5ed -
SPL set ID
74ae2a93-b267-444c-8f0f-a2a6522260ee -
UNII
4GDQ854U53 -
UNII
LW2E03M5PG -
UNII
G70B4ETF4S -
UNII
OTT9J7900I -
RxCUI
1306292 -
RxCUI
1306298
What the source publishes
- Labeler
- Gilead Sciences, Inc.
- Active ingredients
- elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- Stribild
- elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
- ELVITEGRAVIR
- COBICISTAT
- EMTRICITABINE
- TENOFOVIR DISOPROXIL FUMARATE
Complete source data
{
"name": "Stribild",
"splId": "65c2d2eb-d180-41c3-b346-9cdc6e52d5ed",
"labels": [
{
"setId": "74ae2a93-b267-444c-8f0f-a2a6522260ee",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74ae2a93-b267-444c-8f0f-a2a6522260ee",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=74ae2a93-b267-444c-8f0f-a2a6522260ee"
}
],
"routes": [
"ORAL"
],
"labeler": "Gilead Sciences, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-1201-1)",
"package_ndc": "61958-1201-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20120827"
}
],
"productId": "61958-1201_65c2d2eb-d180-41c3-b346-9cdc6e52d5ed",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "61958-1201",
"deaSchedule": null,
"genericName": "elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ELVITEGRAVIR",
"strength": "150 mg/1"
},
{
"name": "COBICISTAT",
"strength": "150 mg/1"
},
{
"name": "EMTRICITABINE",
"strength": "200 mg/1"
},
{
"name": "TENOFOVIR DISOPROXIL FUMARATE",
"strength": "300 mg/1"
}
],
"applicationNumber": "NDA203100",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120827",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000127",
"N0000175887",
"N0000185507",
"N0000190114",
"N0000191001",
"N0000185503",
"N0000182137",
"N0000190107",
"N0000190108",
"N0000190113",
"N0000191423",
"N0000175462",
"M0015066",
"N0000009947"
],
"unii": [
"4GDQ854U53",
"LW2E03M5PG",
"G70B4ETF4S",
"OTT9J7900I"
],
"rxcui": [
"1306292",
"1306298"
],
"spl_set_id": [
"74ae2a93-b267-444c-8f0f-a2a6522260ee"
],
"pharm_class_cs": [
"Nucleosides [CS]"
],
"pharm_class_epc": [
"Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
"Cytochrome P450 3A Inhibitor [EPC]",
"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"HIV Integrase Inhibitors [MoA]",
"Cytochrome P450 2C9 Inducers [MoA]",
"Cytochrome P450 3A Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Cytochrome P450 2D6 Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
"Breast Cancer Resistance Protein Inhibitors [MoA]",
"Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
"Nucleoside Reverse Transcriptase Inhibitors [MoA]"
],
"manufacturer_name": [
"Gilead Sciences, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:61958-1201_65c2d2eb-d180-41c3-b346-9cdc6e52d5ed"